Drug Profile
Research programme: stem cell therapeutics - Histostem
Alternative Names: Cirrhosis HMScs - HistochemLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Histostem
- Class
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alopecia; Diabetes mellitus; Liver cirrhosis; Multiple sclerosis; Osteonecrosis; Osteoporosis; Spinal cord injuries; Thromboangiitis obliterans
- Discontinued Alzheimer's disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Alopecia in South Korea (Parenteral, Infusion)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cirrhosis in South Korea (Parenteral, Infusion)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in South Korea (Parenteral, Infusion)